Amylyx Pharmaceuticals, Inc. AMLX Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s interest income?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported interest income of $2.57M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s interest income changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s interest income increased by 15.2% year-over-year, from $2.23M to $2.57M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s interest income?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s interest income has grown at a 300.9% compound annual growth rate (CAGR), from $36K to $9.3M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.